Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNAseq RAT DIA WT and DMD 12months

ABSTRACT: scRNAseq RAT DIA WT and DMD 12months

PROVIDER: PRJNA814255 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18278840.fastq.gz	Fastqsanger.gz
	SRR18278841.fastq.gz	Fastqsanger.gz
	SRR18278842.fastq.gz	Fastqsanger.gz
	SRR18278843.fastq.gz	Fastqsanger.gz
	SRR18278844.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

scRNAseq RAT DIA WT and DMD 12months

Project description:Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disorder caused by mutations in the Dystrophin gene with no therapeutic option. To bridge the gap between preclinical and therapeutic evaluation studies, we have generated a rat model for DMD that carries an exon 52 deletion (R DMDdel52) causing a complete lack of dystrophin protein. Here we show that R DMDdel52 animals recapitulated human DMD pathophysiological trajectory more faithfully than the mdx mouse model. We report that R DMDdel52 rats displayed progressive and severe skeletal muscle loss associated with fibrotic deposition, fat infiltration and fibre type switch. Early fibrosis was also apparent in the cardiac muscle. These histological modifications led to severe muscle, respiratory and cardiac functional impairments leading to premature death around one year. Moreover, DMD muscle exhibited systemic inflammation with a mixed M1/M2 phenotype. A comparative single cell RNAseq analysis of the diaphragm muscle was performed, revealing cellular populations alteration and molecular modifications in all muscle cell types. We show that DMD fibroadipogenic progenitors produced elevated levels of cartilage oligomeric matrix protein (COMP), a glycoprotein responsible for modulating homeostasis of extracellular matrix, and whose increased concentration correlated with muscle fibrosis both in R DMDdel52 rats and human patients. Fibrosis is a component of tissue remodelling impacting the whole musculature of DMD patients, at the tissue level but most importantly at the functional level. We therefore propose that this specific biomarker can optimize the prognostic monitoring of functional improvement of patients included in clinical trials.

2022-03-14 | GSE198237 | GEO

scRNAseq RAT TA and EOMs WT and DMD 12months

Project description:scRNAseq RAT TA and EOMs WT and DMD 12months

| PRJNA846738 | ENA

snRNAseq RAT HEART WT BMD and DMD 12months

Project description:snRNAseq RAT HEART WT BMD and DMD 12months

| PRJNA975146 | ENA

Boloria dia

Project description:Boloria dia overview

| PRJNA1163491 | ENA

scRNAseq analysis from mixed cell culture from rat optic nerve

Project description:scRNAseq analysis from mixed cell culture from rat optic nerve

2020-10-14 | GSE159452 | GEO

scRNAseq from WT and PRMT1-KO microglia

Project description:scRNAseq of WT and PRMT1-KO microglia during CPZ diet 5 weeks

2022-04-29 | GSE199574 | GEO

scRNAseq RAT TA and EOMs WT and DMD 12months

Project description:Thyroid Stimulating Hormone Receptor signalling restores skeletal muscle stem cell regeneration in Duchenne muscular dystrophy

2023-02-02 | GSE205629 | GEO

Systemic deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model lacking DMD exon 52

Project description:Duchenne muscular dystrophy (DMD) is a fatal X-linked disease caused by mutations in the dystrophin (DMD) gene, leading to the complete absence of DMD and progressive degeneration of skeletal and heart muscles. Expression of an internally shortened dystrophin in DMD subjects (DMDΔ52) can be achieved by skipping DMD exon 51 to reframe the transcript. To predict the best possible outcome of this therapeutic strategy, we generated transgenic pigs lacking DMD exon 51 and 52, additionally representing a new model for Becker muscular dystrophy (BMD). To inspect the proteome alterations caused by the different dystrophin mutations in an unbiased and comprehensive manner, we performed a label-free liquid chromatography-tandem mass spectrometry analysis (LC-MS/MS) of myocardial and skeletal muscle samples from wild-type (WT), DMDΔ52 and DMDΔ51-52 pigs.

2023-07-11 | PXD039533 | Pride

WT and BRM KO scRNAseq at D10

Project description:WT and BRM KO scRNAseq at D10

| PRJNA631418 | ENA

scRNAseq from WT and PRMT1-KO microglia

Project description:scRNAseq from WT and PRMT1-KO microglia

| PRJNA820747 | ENA